We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aging and Cancer Effects (ACE) Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00204880
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : October 5, 2015
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison

Brief Summary:

Hypotheses:

  1. Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains.
  2. Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer.
  3. Some aspect of baseline patient characteristic will be predictive of cancer-related outcomes.

Condition or disease
Breast Cancer Lung Cancer

Study Type : Observational
Actual Enrollment : 34 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment
Study Start Date : February 2005
Primary Completion Date : December 2009
Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Men and women over the age of 55 newly diagnosed with lung, breast, colon or rectal cancer, and with an anticipated life expectancy of at least 2 years for breast cancer patients,1 year for patients with lung cancer, and 2 years for patients with colon or rectal cancer. There is no upper age limit for participation in this study.
Criteria

Inclusion Criteria:

  • Willing to do memory testing
  • Willing to participate in activities of daily living assessment
  • Can use a cane or walker
  • Willing to complete a balance performance assessment, if able.

Exclusion Criteria:

  • Currently receiving treatment for cancer.
  • Has a previous history of brain cancer
  • Significant neurological disease other than AD that might affect cognitive function, such as stroke, Parkinson's disease, multiple sclerosis, or serious traumatic brain injury.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00204880


Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Sanjay Asthana, MD University of Wisconsin, Madison

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00204880     History of Changes
Other Study ID Numbers: 2004-0341
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: October 5, 2015
Last Verified: September 2010